US 12,006,298 B2
Polymorphic compounds and uses thereof
Stephen Gitu Machatha, Wilmington, MA (US); Jonathan J. Loughrey, Edinburgh (GB); Hannah Ruth Mclachlan, Edinburgh (GB); and Gregor Sneddon, Bonnybridge (GB)
Assigned to Aldeyra Therapeutics, Inc., Lexington, MA (US)
Appl. No. 17/265,757
Filed by Aldeyra Therapeutics, Inc., Lexington, MA (US)
PCT Filed Aug. 6, 2019, PCT No. PCT/US2019/045206
§ 371(c)(1), (2) Date Feb. 3, 2021,
PCT Pub. No. WO2020/033344, PCT Pub. Date Feb. 13, 2020.
Claims priority of provisional application 62/715,078, filed on Aug. 6, 2018.
Prior Publication US 2022/0017475 A1, Jan. 20, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 263/57 (2006.01)
CPC C07D 263/57 (2013.01) [C07B 2200/13 (2013.01)] 20 Claims
 
1. Compound A:

OG Complex Work Unit Chemistry
wherein the compound is crystalline.